Klein, H H

Krützfeldt, J; Raasch, W; Klein, H H (2000). Ramipril increases the protein level of skeletal muscle IRS-1 and alters protein tyrosine phosphatase activity in spontaneously hypertensive rats. Naunyn-Schmiedeberg's archives of pharmacology, 362(1), pp. 1-6. Berlin: Springer 10.1007/s002100000234

Krützfeldt, J; Kausch, C; Volk, A; Klein, H H; Rett, K; Häring, H U; Stumvoll, M (2000). Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes, 49(6), pp. 992-8. Alexandria, Va.: American Diabetes Association 10.2337/diabetes.49.6.992

Strack, V; Hennige, A M; Krützfeldt, J; Bossenmaier, B; Klein, H H; Kellerer, M; Lammers, R; Häring, H U (2000). Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta. Diabetologia, 43(4), pp. 443-9. Heidelberg: Springer 10.1007/s001250051327

Krützfeldt, J; Grünweller, A; Raasch, W; Drenckhan, M; Klein, H H (1999). Microtiter well assays for protein tyrosine phosphatase activities directed against phosphorylated insulin receptor or insulin receptor substrate-1. Analytical biochemistry, 271(1), pp. 97-9. San Diego, Calif.: Elsevier 10.1006/abio.1999.4115